Health
Arthritis drug Tocilizumab reduces severe Covid mortality: study – Bangkok Post
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts…
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given…
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Noosa News21 hours agoPalestine protesters forced into last-minute reroute